About 80 percent of clinical trials are oncology trials. Experts shared their insights into where the industry is headed: explosive growth of clinical trials in China, growth in combination trials, use of companion diagnostics to match patients to trials, and how to design better trials that will generate the data we need with as few patients as possible. (Life Science Leader)